Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Bayer plc, 400 South Oak Way, Reading, RG2 6AD
Clarityn Allergy Tablets are indicated for the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
One tablet once daily.
One tablet once daily
For appropriate dosing in children younger than 6 years or with body weight of 30 kg or less, there are other formulations more suitable.
Safety and efficacy of Clarityn Allergy Tablets have not been established. No data are available.
Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine. An initial dose of 10 mg every other day is recommended for adults and children weighing more than 30 kg.
No dosage adjustments are required in patients with renal insufficiency.
No dosage adjustments are required in the elderly.
Oral use. The tablet may be taken without regard to mealtime.
Overdosage with loratadine increased the occurrence of anticholinergic symptoms. Somnolence, tachycardia and headache have been reported with overdoses.
In the event of overdose, general symptomatic and supportive measures are to be instituted and maintained for as long as necessary. Administration of activated charcoal as a slurry with water may be attempted. Gastric lavage may be considered. Loratadine is not removed by haemodialysis and it is not known if loratadine is removed by peritoneal dialysis. Medical monitoring of the patient is to be continued after emergency treatment.
36 months.
This medicinal product does not require any special storage conditions.
Blister comprising 20μm aluminium foil with vinyl heat coating and a 250 μm clear, transparent polyvinylchloride (PVC) film or a 250μm clear, transparent polyvinyl chloride (PVC) film with polyvinylidene chloride (PVdC) coating.
Pack sizes of 7, 10, 14, 20 and 30 tablets.
Not all pack sizes may be marketed.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
